Shihori Tanabe
University of Tokyo
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Shihori Tanabe.
Journal of Biological Chemistry | 2005
Tomomi Fujii; Naoya Onohara; Yoshiko Maruyama; Shihori Tanabe; Hiroyuki Kobayashi; Masashi Fukutomi; Yuichi Nagamatsu; Naoki Nishihara; Ryuji Inoue; Hideki Sumimoto; Futoshi Shibasaki; Taku Nagao; Motohiro Nishida; Hitoshi Kurose
Angiotensin II (Ang II) activates multiple signaling pathways leading to hyperplasia of cardiac fibroblasts. Reactive oxygen species (ROS) produced by Ang II stimulation are assumed to play pivotal roles in this process. Here, we show that ROS mediate Ang II-induced activation of nuclear factor of activated T cells (NFAT) in rat cardiac fibroblasts. Ang II-induced NFAT activation was suppressed by diphenyleneiodonium (an NADPH oxidase inhibitor), dominant negative (DN)-Rac, DN-p47phox, and an inhibitor of Gα12/13 (Gα12/13-specific regulator of G protein signaling domain of p115RhoGEF, p115-regulator of G protein signaling (RGS)). Stimulation of Ang II receptor increased the intracellular ROS level in a Rac- and p47phox-dependent manner. Because p115-RGS suppressed Ang II-induced Rac activation, Ang II receptor-coupled Gα12/13 mediated NFAT activation through ROS production by Rac activation. Ang II-induced nuclear translocation of the green fluorescent protein (GFP)-tagged amino-terminal region of NFAT4 (GFP-NFAT4) was suppressed by p115-RGS or BAPTA but not by diphenyleneiodonium. The expression of constitutively active (CA)-Gα12/13, CA-G translocation α13, or CA-Rac increased the nuclear of GFP-NFAT4. These results suggest that NFAT activity is regulated by both Ca2+-dependent and ROS-dependent pathways. Furthermore, activation of c-Jun NH2-terminal kinase (JNK) induced by Ang II stimulation is required for NFAT activation because Ang II-induced NFAT activation was inhibited by SP600125, a selective JNK inhibitor. These results indicate that Ang II stimulates the nuclear translocation and activation of NFAT by integrated pathways including the activation of Gα12/13, Rac, NADPH oxidase, and JNK and that Gα12/13-mediated ROS production is essential for NFAT transcriptional activation.
Journal of Biochemistry | 2008
Shihori Tanabe; Yoji Sato; Takayoshi Suzuki; Kazuhiro Suzuki; Taku Nagao; Teruhide Yamaguchi
Human mesenchymal stem cells (hMSCs) are multipotent cells that differentiate into several cell types, and are expected to be a useful tool for cellular therapy. Although the hMSCs differentiate into osteogenic cells during early to middle stages, this differentiation capacity decreases during the late stages of cell culture. To test a hypothesis that there are biomarkers indicating the differentiation potential of hMSCs, we performed microarray analyses and profiled the gene expression in six batches of hMSCs (passages 4-28). At least four genes [necdin homolog (mouse) (NDN), EPH receptor A5 (EPHA5), nephroblastoma overexpressed gene (NOV) and runt-related transcription factor 2 (RUNX2)] were identified correlating with the passage numbers in all six batches. The results showed that the osteogenic differentiation capacity of hMSCs is down-regulated in the late stages of cell culture. It seemed that adipogenic differentiation capacity was also down-regulated in late stage of the culture. The cells in late stage are oligopotent and the genes identified in this study have the potential to act as quality-control markers of the osteogenic differentiation capacity of hMSCs.
Methods in Enzymology | 2004
Shihori Tanabe; Barry Kreutz; Nobuchika Suzuki; Tohru Kozasa
Abstract Three mammalian Rho guanine nucleotide exchange factors (RhoGEFs), leukemia-associated RhoGEF (LARG), p115RhoGEF, and PDZ-RhoGEF, contain regulator of G-protein signaling (RGS) domains within their amino-terminal regions. These RhoGEFs link signals from heterotrimeric G12/13 protein-coupled receptors to Rho GTPase activation, leading to various cellular responses, such as actin reorganization and gene expression. The activity of these RhoGEFs is regulated by Gα12/13 through their RGS domains. Because RhoGEFs stimulate guanine nucleotide exchange by Rho GTPases, RhoGEF activation can be measured by monitoring GTP binding to or GDP dissociation from Rho GTPases. This article describes methods used to perform reconstitution assays to measure the activity of RhoGEFs regulated by Gα12/13.
Journal of Biological Chemistry | 2010
Motohiro Nishida; Reiko Suda; Yuichi Nagamatsu; Shihori Tanabe; Naoya Onohara; Michio Nakaya; Yasunori Kanaho; Takahiro Shibata; Koji Uchida; Hideki Sumimoto; Yoji Sato; Hitoshi Kurose
Pertussis toxin (PTX) is recognized as a specific tool that uncouples receptors from Gi and Go through ADP-ribosylation. During the study analyzing the effects of PTX on Ang II type 1 receptor (AT1R) function in cardiac fibroblasts, we found that PTX increases the number of AT1Rs and enhances AT1R-mediated response. Microarray analysis revealed that PTX increases the induction of interleukin (IL)-1β among cytokines. Inhibition of IL-1β suppressed the enhancement of AT1R-mediated response by PTX. PTX increased the expression of IL-1β and AT1R through NF-κB, and a small GTP-binding protein, Rac, mediated PTX-induced NF-κB activation through NADPH oxidase-dependent production of reactive oxygen species. PTX induced biphasic increases in Rac activity, and the Rac activation in a late but not an early phase was suppressed by IL-1β siRNA, suggesting that IL-1β-induced Rac activation contributes to the amplification of Rac-dependent signaling induced by PTX. Furthermore, inhibition of TLR4 (Toll-like receptor 4) abolished PTX-induced Rac activation and enhancement of AT1R function. However, ADP-ribosylation of Gi/Go by PTX was not affected by inhibition of TLR4. Thus, PTX binds to two receptors; one is TLR4, which activates Rac, and another is the binding site that is required for ADP-ribosylation of Gi/Go.
Cellular and Molecular Neurobiology | 2009
Kayoko Fujishita; Tetsuro Ozawa; Keisuke Shibata; Shihori Tanabe; Yoji Sato; Masashi Hisamoto; Tohru Okuda; Schuichi Koizumi
Grape polyphenols are known to protect neurons against oxidative stress. We used grape seed extract (GSE) from “Koshu” grapes (Vitis vinifera) containing a variety of polyphenols, and performed transcriptome analysis to determine the effects of GSE on primary cultures of astrocytes in the hippocampus. GSE upregulated various mRNAs for cytokines, among which interleukin-6 (IL-6) showed the biggest increase after treatment with GSE. The GSE-evoked increase in IL-6 mRNAs was confirmed by quantitative RT-PCR. We also detected IL-6 proteins by ELISA in the supernatant of GSE-treated astrocytes. We made an oxidative stress-induced neuronal cell death model in vitro using a neuron rich culture of the hippocampus. Treatment of the neurons with H2O2 caused neuronal cell death in a time- and concentration-dependent manner. Exogenously applied IL-6 protected against the H2O2-induced neuronal cell death, which was mimicked by endogenous IL-6 produced by GSE-treated astrocytes. Taken together, GSE acting on astrocytes increased IL-6 production, which functions as a neuroprotective paracrine, could protect neuronal cells from death by oxidative stress.
Journal of Biological Chemistry | 2005
Motohiro Nishida; Shihori Tanabe; Yoshiko Maruyama; Supachoke Mangmool; Kyoji Urayama; Yuichi Nagamatsu; Shuichi Takagahara; Justin H. Turner; Tohru Kozasa; Hiroyuki Kobayashi; Yoji Sato; Toru Kawanishi; Ryuji Inoue; Taku Nagao; Hitoshi Kurose
Journal of Biological Chemistry | 2005
Motohiro Nishida; Shihori Tanabe; Yoshiko Maruyama; Supachoke Mangmool; Kyoji Urayama; Yuichi Nagamatsu; Shuichi Takagahara; Justin H. Turner; Tohru Kozasa; Hiroyuki Kobayashi; Yoji Sato; Toru Kawanishi; Ryuji Inoue; Taku Nagao; Hitoshi Kurose
Molecular Pharmacology | 2003
Ken Arai; Yoshiko Maruyama; Motohiro Nishida; Shihori Tanabe; Shuichi Takagahara; Tohru Kozasa; Yasuo Mori; Taku Nagao; Hitoshi Kurose
Journal of Biological Chemistry | 2001
Takako Shiina; Ken Arai; Shihori Tanabe; Norihiro Yoshida; Tatsuya Haga; Taku Nagao; Hitoshi Kurose
Molecular Pharmacology | 2004
Susumu Nakamura; Barry Kreutz; Shihori Tanabe; Nobuchika Suzuki; Tohru Kozasa